APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms (Q50661971)

17 March 2018

http://europepmc.org/abstract/MED/24492349

title

APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms (English)

1 reference

17 March 2018

http://europepmc.org/abstract/MED/24492349

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

María Teresa Bobes Bascarán

3 June 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

C Conejero-Goldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

T M Hyde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

J E Kleinman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

M M Herman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

P Davies

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

T E Goldberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

4 February 2014

1 reference

17 March 2018

http://europepmc.org/abstract/MED/24492349

published in

Molecular Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

1243-1250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

Apolipoprotein e sets the stage: response to injury triggers neuropathology

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Association of apolipoprotein E genotypes with lipid levels and coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

APOE genotype, lipids, and coronary heart disease risk: a prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Linking lipids to Alzheimer's disease: cholesterol and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

The role of apolipoprotein E in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

ApoE promotes the proteolytic degradation of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

ApoE isoform affects LTP in human targeted replacement mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Neuronal activity regulates the regional vulnerability to amyloid-β deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Extracellular matrix inhibits structural and functional plasticity of dendritic spines in the adult visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

The perineuronal net and the control of CNS plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

The apolipoprotein E epsilon 2 allele and decline in episodic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

The association of apolipoprotein E polymorphism with memory: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.194

Function and comorbidities of apolipoprotein e in Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E.

1 reference

12 December 2020

Integrin requirement for hippocampal synaptic plasticity and spatial memory

1 reference

12 December 2020

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

1 reference

12 December 2020

Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene"

1 reference

12 December 2020

Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.

1 reference

12 December 2020

Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2013.194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24492349%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference